Glucotrack (GCTK) EBITDA Margin (2014 - 2020)
Glucotrack (GCTK) reported EBITDA Margin of 617525.77% for Q2 2020, down 61671835.0% year-on-year from N/an in Q3 2019, and down 1777.62% quarter-over-quarter from 32888.68% in Q1 2020.
Glucotrack (GCTK) has 7 years of EBITDA Margin data on file, last reported at 617525.77% in Q2 2020.
- For the quarter ending Q2 2020, EBITDA Margin fell 61671835.0% year-over-year to 617525.77%; the trailing twelve-month figure through Sep 2020 stood at 6658.35% (up 969995.0% YoY), and the FY2019 full-year result was 1709.62%, up 1702847.0% from the prior year.
- EBITDA Margin for Q2 2020 stood at 617525.77%, down from 32888.68% in the prior quarter.
- Across five years, EBITDA Margin topped out at 9599.1% in Q4 2019 and bottomed at 617525.77% in Q2 2020.
- A 5-year average of 45380.89% and a median of 2763.6% in 2019 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 1622378 bps in 2018 and slumped 61671835 bps in 2020, its largest moves.
- Tracing GCTK's EBITDA Margin over 5 years: stood at 892.92% in 2016, then surged by 532 bps to 3861.38% in 2017, then slumped by 428 bps to 12658.92% in 2018, then soared by 176 bps to 9599.1% in 2019, then plunged by 6533 bps to 617525.77% in 2020.
- According to Business Quant data, EBITDA Margin over the past three periods registered 617525.77%, 32888.68%, and 9599.1% for Q2 2020, Q1 2020, and Q4 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -617,525.77% |
| Mar 31, 2020 | -32,888.68% |
| Dec 31, 2019 | 9,599.10% |
| Sep 30, 2019 | -23,946.44% |
| Jun 30, 2019 | -807.42% |
| Mar 31, 2019 | -4,126.44% |
| Jun 30, 2018 | -12,658.92% |
| Mar 31, 2018 | 6,524.48% |
| Dec 31, 2017 | 3,861.38% |
| Sep 30, 2017 | -12,424.96% |
| Jun 30, 2017 | -28,882.71% |
| Mar 31, 2017 | 2,595.25% |
| Dec 31, 2016 | -892.92% |
| Sep 30, 2016 | -12,701.02% |
| Jun 30, 2016 | -418.37% |
| Mar 31, 2016 | -1,400.77% |
| Jun 30, 2015 | -2,330.53% |
| Mar 31, 2015 | -2,078.73% |
| Dec 31, 2014 | -2,380.65% |
| Sep 30, 2014 | -2,715.88% |